Impact of Nosocomial Infection on in-Hospital Mortality Rate in Adult Patients Under Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Surgery
Xiyuan Li,Xiaomeng Wang,Liangshan Wang,Chenglong Li,Xing Hao,Zhongtao Du,Haixiu Xie,Feng Yang,Hong Wang,Xiaotong Hou
DOI: https://doi.org/10.2147/IDR.S390599
2023-06-28
Infection and Drug Resistance
Abstract:Xiyuan Li, 1, 2 Xiaomeng Wang, 1 Liangshan Wang, 1 Chenglong Li, 1 Xing Hao, 1 Zhongtao Du, 1 Haixiu Xie, 1 Feng Yang, 1 Hong Wang, 1 Xiaotong Hou 1 1 Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China; 2 Department of Intensive Care Unit, Aviation General Hospital of China Medical University, Beijing, 100012, People's Republic of China Correspondence: Xiaotong Hou; Hong Wang, Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, People's Republic of China, Tel +86 10 64456631 ; +86 15010516438, Email ; Objective: There was no consensus on the impact of nosocomial infection on In-hospital mortality rate in patients receiving ECMO. This study aimed to investigate the impact of nosocomial infection (NI) on In-hospital mortality rate in adult patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO) after cardiac surgery. Materials and Methods: This retrospective study included 503 adult patients who underwent VA-ECMO after cardiac surgery. The impact of time-dependent NIs on In-hospital mortality rate within 28 days of ECMO initiation was investigated using a Cox regression model. The cumulative incidence function for death was compared between patients with NIs and those without NIs using a competing risk model. Results: Within 28 days after ECMO initiation, 206 (41.0%) patients developed NIs, and 220 (43.7%) patients died. The prevalence rates of NIs were 27.8% and 20.3% during and after ECMO therapy, respectively. The incidence rates of NIs during and after ECMO therapy were 49‰ and 25‰, respectively. Time-dependent NI was an independent risk factor for predicting death (hazard ratio = 1.05, 95% confidence interval = 1.00– 1.11). The cumulative incidence of death in patients with NI was significantly higher than that in patients without NI at each time point within 28 days of ECMO initiation. (Z = 5.816, P = 0.0159). Conclusion: NI was a common complication in adult patients who received VA-ECMO after cardiac surgery, and time-dependent NI was an independent risk factor for predicting mortality in these patients. Using a competing risk model, we confirmed that NIs increased the risk of In-hospital mortality rate in these patients. Keywords: venoarterial extracorporeal membrane oxygenation, nosocomial infection, in-hospital mortality rate, Cox regression, competing risk model Data adapted from the Extracorporeal Life Support Organization indicated that more than 2000 extracorporeal membrane oxygenation (ECMO) runs were performed per year from 2014 to 2016 in adult patients. 1 The use of ECMO post-cardiotomy plays an important role in clinical practice. The rate of venoarterial extracorporeal membrane oxygenation (VA-ECMO) applications has increased in recent decades. 1 However, even in developed countries with the most advanced medical care, the In-hospital mortality rate of patients receiving VA-ECMO therapy is as high as 57.2%. 2 Improving the survival of patients receiving ECMO has become a hot topic in various medical units. Nosocomial infection (NI) is a common complication in adult patients on ECMO. There is no consensus on whether NI increases In-hospital mortality rate in these patients. Several studies have presented similar opinions, 3–10 whereas others have reported contradictory views. 11–25 Traditional research methods have difficulty removing the time-dependent bias and competing risk bias; 26–30 therefore, the adverse effects of NIs in patients receiving VA-ECMO could not be accurately disclosed. Several studies have pointed out 29,31,32 that using competitive risk models instead of traditional methods to explore the impact of NI on In-hospital mortality rate is a key factor in reducing the competing bias. This study aimed to clarify the impact of NI on In-hospital mortality rate within 28 days of ECMO initiation in patients receiving VA-ECMO after cardiac surgery. This retrospective observational study was conducted in the surgical intensive care unit (ICU) of a single cardiac center in Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Since the initiation of ECMO therapy in 2004, the complete data of more than 1100 patients receiving ECMO therapy have been available in the electronic medical records system. This study included adult patients who received VA-ECMO after cardiac surgery -Abstract Truncated-
pharmacology & pharmacy,infectious diseases